CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Perdagangan Calcimedica Inc - CALC CFD

4.8609
6.86%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.3682
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.024874%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
0.002651%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 0.001
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 5.2188
Open* 5.1867
1-Year Change* 314.94%
Day's Range* 4.8609 - 5.3763
52 wk Range 4.88-20.30
Average Volume (10 days) 36.06K
Average Volume (3 months) 150.00K
Market Cap 27.59M
P/E Ratio -100.00K
Shares Outstanding 5.52M
Revenue N/A
EPS -23.21
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date May 8, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 29, 2023 4.8609 -0.3258 -6.28% 5.1867 5.4138 4.8597
Mar 28, 2023 5.2188 -0.1502 -2.80% 5.3690 5.8530 4.9029
Mar 27, 2023 5.5461 0.1553 2.88% 5.3908 6.0853 5.3883
Mar 24, 2023 5.5507 0.0832 1.52% 5.4675 5.7853 5.4675
Mar 23, 2023 5.4929 0.1525 2.86% 5.3404 5.8023 5.3404
Mar 22, 2023 5.5768 0.2301 4.30% 5.3467 6.5507 5.0805
Mar 21, 2023 6.0468 1.2311 25.56% 4.8157 6.1436 4.7284
Mar 20, 2023 5.3451 -0.6469 -10.80% 5.9920 5.9920 5.0602
Mar 17, 2023 0.4280 -0.0478 -10.05% 0.4758 0.4763 0.4273
Mar 16, 2023 0.4761 -0.0195 -3.93% 0.4956 0.4958 0.4580
Mar 15, 2023 0.4937 0.0277 5.94% 0.4660 0.4969 0.4660
Mar 14, 2023 0.4762 -0.0145 -2.95% 0.4907 0.4957 0.4737
Mar 13, 2023 0.4960 -0.0093 -1.84% 0.5053 0.5151 0.4859
Mar 10, 2023 0.5041 0.0008 0.16% 0.5033 0.5120 0.4857
Mar 9, 2023 0.5346 -0.0034 -0.63% 0.5380 0.5637 0.5164
Mar 8, 2023 0.5638 0.0408 7.80% 0.5230 0.5647 0.5230
Mar 7, 2023 0.5637 0.0395 7.54% 0.5242 0.5823 0.5242
Mar 6, 2023 0.5556 -0.0273 -4.68% 0.5829 0.5829 0.5537
Mar 3, 2023 0.5476 0.0429 8.50% 0.5047 0.5588 0.5047
Mar 2, 2023 0.5345 0.0292 5.78% 0.5053 0.5347 0.5053

Calcimedica Inc Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Total Operating Expense 36.18 35.947 29.832 37.502 28.57
Selling/General/Admin. Expenses, Total 19.104 17.044 8.87 6.922 5.599
Research & Development 14.113 18.903 20.962 30.58 22.971
Operating Income -36.18 -35.947 -29.832 -37.502 -28.57
Interest Income (Expense), Net Non-Operating 0.575 0.126 0.143 0.393 0.192
Other, Net 0 2.158 0.072 0
Net Income Before Taxes -35.605 -35.821 -27.531 -37.037 -28.378
Net Income After Taxes -35.605 -35.821 -27.531 -37.037 -28.378
Net Income Before Extra. Items -35.605 -35.821 -27.531 -37.037 -28.378
Net Income -35.605 -35.821 -27.531 -37.037 -28.378
Total Adjustments to Net Income 0 -7.189 -7.055 -4.317
Income Available to Common Excl. Extra. Items -35.605 -35.821 -34.72 -44.092 -32.695
Income Available to Common Incl. Extra. Items -35.605 -35.821 -34.72 -44.092 -32.695
Diluted Net Income -35.605 -35.821 -34.72 -44.092 -32.695
Diluted Weighted Average Shares 1.53498 1.51427 1.50317 1.36829 1.36829
Diluted EPS Excluding Extraordinary Items -23.1957 -23.6557 -23.0978 -32.2243 -23.8949
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -21.2654 -23.6557 -23.0978 -32.2243 -23.8949
Unusual Expense (Income) 2.963
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total revenue 0 0 0 0 0
Total Operating Expense 7.712 9.983 8.301 10.184 8.701
Selling/General/Admin. Expenses, Total 6.435 4.299 4.243 4.127 4.433
Research & Development 0.749 3.249 4.058 6.057 4.268
Operating Income -7.712 -9.983 -8.301 -10.184 -8.701
Interest Income (Expense), Net Non-Operating 0.309 0.171 0.06 0.035 0.026
Other, Net 0
Net Income Before Taxes -7.403 -9.812 -8.241 -10.149 -8.675
Net Income After Taxes -7.403 -9.812 -8.241 -10.149 -8.675
Net Income Before Extra. Items -7.403 -9.812 -8.241 -10.149 -8.675
Net Income -7.403 -9.812 -8.241 -10.149 -8.675
Total Adjustments to Net Income 0
Income Available to Common Excl. Extra. Items -7.403 -9.812 -8.241 -10.149 -8.675
Income Available to Common Incl. Extra. Items -7.403 -9.812 -8.241 -10.149 -8.675
Diluted Net Income -7.403 -9.812 -8.241 -10.149 -8.675
Diluted Weighted Average Shares 1.54484 1.53836 1.53099 1.52559 1.52415
Diluted EPS Excluding Extraordinary Items -4.79207 -6.37822 -5.3828 -6.65253 -5.69171
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -4.45029 -4.79536 -5.3828 -6.65253 -5.69171
Unusual Expense (Income) 0.528 2.435
  • Annual
  • Quarterly
2021 2020 2019 2018
Total Current Assets 67.078 99.24 36.271 13.445
Cash and Short Term Investments 63.67 95.033 35.956 12.834
Cash & Equivalents 13.364 33.418 15.87 12.834
Short Term Investments 50.306 61.615 20.086 0
Prepaid Expenses 2.034 4.207 0.315 0.611
Total Assets 69.088 101.794 40.66 17.813
Property/Plant/Equipment, Total - Net 1.981 1.946 1.975 1.515
Property/Plant/Equipment, Total - Gross 3.634 3.08 2.714 1.958
Accumulated Depreciation, Total -1.653 -1.134 -0.739 -0.443
Other Long Term Assets, Total 0.029 0.608 2.414 2.853
Total Current Liabilities 4.057 6.997 12.251 5.794
Accounts Payable 0.527 2.513 4.636 2.523
Accrued Expenses 2.582 3.658 4.377 2.924
Notes Payable/Short Term Debt 0 0 0 0
Other Current Liabilities, Total 0.948 0.826 3.238 0.347
Total Liabilities 4.065 7.008 12.251 5.794
Total Long Term Debt 0 0 0 0
Total Equity 65.023 94.786 28.409 12.019
Preferred Stock - Non Redeemable, Net 0 0 131.363 78.811
Common Stock 0.002 0.002 0 0
Additional Paid-In Capital 234.225 228.155 2.879 2.007
Retained Earnings (Accumulated Deficit) -169.188 -133.367 -105.836 -68.799
Unrealized Gain (Loss) -0.016 -0.004 0.003 0
Total Liabilities & Shareholders’ Equity 69.088 101.794 40.66 17.813
Total Common Shares Outstanding 21.3578 20.9793 19.1556 19.1556
Other Liabilities, Total 0.008 0.011
Total Preferred Shares Outstanding 0
Total Receivables, Net 0.021
Other Current Assets, Total 1.353
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 58.222 67.078 74.496 76.051 88.821
Cash and Short Term Investments 55.28 63.67 72.554 73.586 85.688
Cash & Equivalents 8.36 13.364 11.452 7.864 10.589
Short Term Investments 46.92 50.306 61.102 65.722 75.099
Prepaid Expenses 2.942 3.408 1.942 2.465 3.133
Total Assets 60.586 69.088 76.638 82.821 90.852
Property/Plant/Equipment, Total - Net 2.335 1.981 2.113 2.006 2.002
Other Long Term Assets, Total 0.029 0.029 0.029 0.136 0.029
Total Current Liabilities 4.228 4.057 4.49 4.141 6.278
Accounts Payable 0.541 0.527 2.066 2.101 1.956
Accrued Expenses 2.216 2.582 1.729 1.543 3.378
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 1.471 0.948 0.695 0.497 0.944
Total Liabilities 4.33 4.065 4.502 4.154 6.29
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.102 0.008 0.012 0.013 0.012
Total Equity 56.256 65.023 72.136 78.667 84.562
Common Stock 0.002 0.002 0.002 0.002 0.002
Additional Paid-In Capital 235.767 234.225 232.641 231.183 229.376
Retained Earnings (Accumulated Deficit) -179.337 -169.188 -160.513 -152.524 -144.816
Unrealized Gain (Loss) -0.176 -0.016 0.006 0.006 0
Total Liabilities & Shareholders’ Equity 60.586 69.088 76.638 82.821 90.852
Total Common Shares Outstanding 21.3578 21.3578 21.3166 21.2847 21.0559
Long Term Investments 4.628
Preferred Stock - Non Redeemable, Net 0 0
  • Annual
  • Quarterly
2021 2020 2019 2018
Net income/Starting Line -35.821 -27.531 -37.037 -28.378
Cash From Operating Activities -31.5 -32.064 -31.215 -28.216
Cash From Operating Activities 0.519 0.395 0.303 0.175
Non-Cash Items 5.433 -0.369 0.598 0.366
Changes in Working Capital -1.631 -4.559 4.921 -0.379
Cash From Investing Activities 10.751 -42.56 -20.62 -1.461
Capital Expenditures -0.488 -1.023 -0.605 -1.461
Other Investing Cash Flow Items, Total 11.239 -41.537 -20.015 0
Cash From Financing Activities 0.695 92.172 54.871 42.019
Financing Cash Flow Items 0 -4.16 -0.045 0
Issuance (Retirement) of Stock, Net 0.695 96.332 54.916 42.019
Net Change in Cash -20.054 17.548 3.036 12.342
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -10.149 -35.821 -27.146 -19.157 -11.449
Cash From Operating Activities -6.524 -31.5 -22.545 -17.045 -9.264
Cash From Operating Activities 0.122 0.519 0.383 0.247 0.118
Non-Cash Items 3.81 5.433 3.946 2.508 1.169
Changes in Working Capital -0.307 -1.631 0.272 -0.643 0.898
Cash From Investing Activities 1.52 10.751 -0.035 -9.096 -13.657
Capital Expenditures 0 -0.488 -0.484 -0.304 -0.136
Other Investing Cash Flow Items, Total 1.52 11.239 0.449 -8.792 -13.521
Cash From Financing Activities 0 0.695 0.614 0.587 0.092
Financing Cash Flow Items 0 0 0 0
Issuance (Retirement) of Stock, Net 0 0.695 0.614 0.587 0.092
Net Change in Cash -5.004 -20.054 -21.966 -25.554 -22.829
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Deerfield Management Company, L.P. Hedge Fund 6.8373 377265 0 2022-12-31 MED
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 5.3895 297380 -2 2023-03-24 LOW
Wilson (Robert N) Individual Investor 11.5614 181655 181655 2023-03-20
BML Capital Management LLC Investment Advisor 1.6 88282 0 2022-12-31 MED
Breuil (Robert S) Individual Investor 0.6207 34246 29340 2023-03-23 HIGH
Zamiri (Parisa) Individual Investor 0.6002 33117 30424 2023-03-23 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.5436 29995 13 2022-12-31 LOW
CVF 2018, LLC Corporation 0.3531 19485 -56817 2021-12-31
First Manhattan Co. LLC Investment Advisor 0.3512 19381 -1476 2022-12-31 LOW
Stauderman (Kenneth A. Ph.D.) Individual Investor 0.7602 11944 11944 2023-03-20
Renaissance Technologies LLC Hedge Fund 0.2019 11143 -3178 2022-12-31 HIGH
Guerard (Frederic) Individual Investor 0.0388 8409 1218 2022-12-01 LOW
BNY Mellon Asset Management Investment Advisor 0.1297 7159 -54 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.0857 4730 -12 2022-12-31 LOW
Johnson & Johnson Innovation-JJDC, Inc. Venture Capital 0.0641 3539 0 2022-12-31 LOW
Susquehanna International Group, LLP Investment Advisor 0.0581 3204 -1313 2022-12-31 MED
Hatteras Venture Partners Venture Capital 0.0557 3076 -111584 2021-12-31 LOW
Bridgeway Capital Management, LLC Investment Advisor 0.0542 2993 -1578 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.0454 2505 0 2022-12-31 LOW
Bjerkholt (Eric H) Individual Investor 0.0259 1429 1429 2023-03-23 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Bio Therapeutic Drugs

505 Coast Boulevard South
Suite 307
LA JOLLA
CALIFORNIA 92037
US

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

74.03 Price
-0.120% 1D Chg, %
Biaya inap posisi Long -0.0170%
Biaya inap posisi short -0.0049%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Natural Gas

2.13 Price
+0.280% 1D Chg, %
Biaya inap posisi Long -0.4441%
Biaya inap posisi short 0.4222%
Waktu biaya inap 21:00 (UTC)
Spread 0.005

US100

12,974.50 Price
-0.020% 1D Chg, %
Biaya inap posisi Long -0.0249%
Biaya inap posisi short 0.0027%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Gold

1,975.68 Price
-0.010% 1D Chg, %
Biaya inap posisi Long -0.0180%
Biaya inap posisi short 0.0098%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda